Endovasc Receives Feedback From the FDA Regarding Liprostin
MONTGOMERY, Texas
ZA Consulting LLC
David Zazoff, 212-505-5976
david@za-consulting.net
Endovasc Inc. (OTCBB: EVSC) announced...
Endovasc Announces Stock Repurchase Program
MONTGOMERY, Texas
Investor Relations for Endovasc Inc.
David Zazoff, 212-505-5976
PressReleases@za-consulting.net
The Board of Directors of...
Alan Lumsden MD to Join Endovasc's Scientific Advisory Committee
MONTGOMERY, Texas
Investor Relations for Endovasc Inc.
David Zazoff, 212-505-5976
PressReleases@za-consulting.net
Endovasc...
Endovasc Issues Update on Liprostin
MONTGOMERY, Texas
Endovasc, Inc.
by
ZA Consulting LLC
David Zazoff, 212-505-5976
david@za-consulting.net
Endovasc, Inc. (OTCBB:EVSC), announced...
Endovasc Adds Additional Member to Advisory Committee
MONTGOMERY, Texas
Endovasc Inc.
Investor Relations:
David Zazoff, 212-505-5976
PressReleases@za-consulting.net
Endovasc Inc. (OTCBB:...
Endovasc's Muscle Enhancing Technology, Endothil-CR, Showcased at the Arnold Classic in Columbus, Ohio
MONTGOMERY, Texas
ZA Consulting LLC
David Zazoff, 212-505-5976
Endovasc, Inc - (OTCBB:...
Yong-Jian Geng, MD, PhD Joins Endovasc Advisory Board
MONTGOMERY, Texas--(BUSINESS WIRE)--Feb. 9, 2005--Endovasc Inc. (OTCBB: EVSC), an early-stage drug development company that pioneers new...